13.12.2018 | Letter to the Editor
Successful retreatment with 3-week rituximab-bendamustine with high-dose dexamethasone in patients with relapsed/refractory mantle cell lymphoma
Erschienen in: Annals of Hematology | Ausgabe 6/2019
Einloggen, um Zugang zu erhalten